Iregene Therapeutics Co., Ltd.
Clinical trials sponsored by Iregene Therapeutics Co., Ltd., explained in plain language.
-
Brain cell injection trial hopes to ease Parkinson's symptoms
Disease control Recruiting nowThis early-phase trial tests a new treatment called NouvNeu001 for people with advanced Parkinson's disease. It involves injecting special brain cells directly into areas of the brain that control movement. The study will enroll just 5 participants to see if the procedure is safe…
Phase: PHASE1, PHASE2 • Sponsor: iRegene Therapeutics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Brain cell transplant trial offers hope for rare Parkinson's-Like disease
Disease control Recruiting nowThis early-stage trial tests a single injection of dopamine-producing cells directly into the brain for people with multiple system atrophy (MSA), a rare and severe movement disorder. The main goal is to check safety and side effects in 9 participants aged 30 to 70. Researchers w…
Phase: PHASE1 • Sponsor: iRegene Therapeutics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC